Abstract
Introduction and ObjectivesPulmonary hypertension (PH) is increasingly recognised as a major contributor to poorer outcomes in pulmonary sarcoidosis. Current treatment guidelines for sarcoidosis associated pulmonary hypertension (SAPH) recommend the optimisation...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have